Hospital
Ralph Lauren Center for Cancer Care and Prevention
Ralph Lauren Center for Cancer Care and Prevention was paid $1.19M by Medicaid between Sep 2019 and Nov 2024, across 25 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 45% of everything it billed.
33Billing provider infoRALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION
NEW YORK, NY 10035
NEW YORK, NY 10035
33aNPI1770046351assigned 04/10/2019
33bProvider typeSpecial Hospital
28Total paid$1.19M
24GClaims27,107
24DCodes billed25
24AFirst – last monthSep 2019 – Nov 2024
Compared with peers
Next to other Special Hospital providers in New York
Rank by total paid#3 of 6
Median peer was paid$182K
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 717 | $3K | |
| 2020 | 3,335 | $128K | |
| 2021 | 6,657 | $258K | |
| 2022 | 6,653 | $310K | |
| 2023 | 6,196 | $307K | |
| 2024incomplete | 3,549 | $181K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 45% | 5,466 | 4,679 | $530K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 24% | 1,648 | 1,042 | $283K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 7.6% | 1,944 | 1,836 | $90K |
| 80053 | Comprehensive metabolic panel | 7.0% | 3,571 | 2,731 | $83K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6.6% | 1,851 | 1,819 | $78K |
| 36591 | 2.7% | 1,114 | 777 | $32K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 1,209 | 1,072 | $15K |
| 96402 | 1.1% | 252 | 205 | $13K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 3,894 | 2,803 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 33 | 25 | $9K |
| J0185 | Injection, aprepitant, 1 mg | <1% | 74 | 50 | $8K |
| 96417 | <1% | 230 | 131 | $7K |
13 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 2,822 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,764 | $4K |
| 96367 | <1% | 18 | $4K | |
| 85027 | <1% | 275 | $4K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 138 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 57 | $2K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | <1% | 14 | $2K |
| 76641 | <1% | 167 | $1K | |
| 82728 | <1% | 123 | $719.15 | |
| 90686 | <1% | 12 | $228.52 | |
| 86300 | <1% | 13 | $82.66 | |
| 82565 | <1% | 96 | $30.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 322 | $11.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIASIO, ANTHONY (SENIOR VICE PRESIDENT, FINANCIAL PL)
Parent organizationMEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES